Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Grand View Research | PRODUCT CODE: 1405751

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405751

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 105 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 46.58 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2022, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.55% in 2022; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.
Show more
Product Code: GVR-1-68038-292-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. CHF Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. CHF Treatment Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. CHF Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. CHF Treatment Devices Market: Key Takeaways
  • 4.2. CHF Treatment Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ventricular Assist Devices (VADs)
    • 4.3.1. Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Counter Pulsation Devices
    • 4.4.1. Counter pulsation devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Implantable Cardioverter Defibrillators
    • 4.5.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pacemakers
    • 4.6.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cardiac Resynchronization Therapy
    • 4.7.1. Cardiac resynchronization therapy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CHF Treatment Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. CHF Treatment Devices Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Jarvik Heart Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. ReliantHeart, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biotronik SE & Co. KG
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Berlin Heart GmbH
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Abbott (St. Jude Medical)
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Boston Scientific Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Teleflex, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-292-1

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait CHF treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 CHF treatment devices: market outlook
  • Fig. 9 CHF treatment devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 CHF treatment devices market driver impact
  • Fig. 15 CHF treatment devices market restraint impact
  • Fig. 16 CHF treatment devices market strategic initiatives analysis
  • Fig. 17 CHF treatment devices market: Product movement analysis
  • Fig. 18 CHF treatment devices market: Product outlook and key takeaways
  • Fig. 19 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 LVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 RVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BiVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Counter Pulsation Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Implantable Cardioverter Defibrillators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Transvenous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Subcutaneous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 External pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cardiac Resynchronization therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cardiac Resynchronization Therapy-Defibrillators (CRT-D) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global CHF treatment devices market: Regional movement analysis
  • Fig. 34 Global CHF treatment devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!